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Macrophages and neutrophils are phagocytes that play major
roles in the onset and maintenance of many diseases. These
two cell types that belong to the innate immune system are
extremely plastic and can move between different modes of
activation upon cues received from their immediatemicroen-
vironment [1–3]. Once activated, these cells secrete myriad of
mediators that shape and regulate the microenvironment, as
well as other immune cells, such that this continuous dialogue
determines the direction of the immune response and its
outcome [4]. This is highlighted in this issue as we focus
on the role of macrophages and neutrophils in both cancer
and autoimmune diseases. Although these are different dis-
eases, with opposing pathophysiologies and activation of the
immune system, some similarities do exist [5]. By comparing
these two cell populations in cancer and autoimmune dis-
eases, in the context of their respective microenvironment,
we try to examine whether there are similar attributes that
could potentially be exploited as new therapeutic strategies.
Most of the manuscripts in this issue are dedicated to
cancer and the tumor microenvironment (TME), reflecting
the abundance of information on macrophages, and the
now growing recognition of the role that neutrophils play
in the cancerous context. In contrast, the role that both
macrophage and neutrophils play in autoimmune diseases is
only beginning to emerge and merits more investigation.
We begin with the remote microenvironment. As the
TME can remotely affect circulating blood cells, O. Balacescu
et al. performed transcriptional analysis in blood samples
derived from triple negative (HER2-ve) breast cancer patients
(TNBC).These studies revealed distinctmolecular signatures
according to estrogen and progesterone receptor (ER and PR)
status. They found significant enrichment of altered systemic
immune-related pathways in the blood of TNBC patients
and this correlated with an increase in inflammation and
necrosis in primary tumors. The authors also propose that
immunotherapy could possibly be synergistic to chemother-
apy to improve the clinical outcome of these patients.
In a series of papers, the role of macrophages in cancer is
addressed, as well as their potential to become targets or vehi-
cles of therapy. C. Eyileten et al. highlight the role of immune
cells and the cellular factors they produce, in promoting or
preventing cancer development. They describe how these
cells, which include tumor-associated macrophages (TAMs),
dendritic cells, neutrophils, T cells, and NK cells, can be
targeted or exploited to induce antitumor immunity and
discuss the pioneering studies where these cells have been
manipulated to exhibit antitumor activity.
The ability of TAMs to produce IL-6 and activate STAT3
has been associatedwith chemoresistance andpoor prognosis
in several cancers including colorectal carcinoma. How-
ever, it remains unclear whether anticytokine therapy could
reverse this, help regain chemosensitivity, and enhance the
suppressive effect of chemotherapy on tumor growth. Z.-
Y. Wang et al. demonstrate that treatment of carboplatin
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increased IL-6 production and STAT3 activation in a dose-
dependent manner in the human colorectal LoVo cells,
whereas anti-IL-6 neutralizing antibody enhanced their
chemosensitivity to carboplatin, abolished STAT3 activation,
and increased cell apoptosis. These results suggest a new way
to increase the efficacy of chemotherapy.
Nonresolving inflammation is one of the consistent fea-
tures of the tumor microenvironment and in the intestine;
this plays a critical role in the initiation and develop-
ment of colon cancer. In the study by Y. Wang et al., the
inhibitory effect of a novel soy-protein-derived isoflavonoid
on inflammation-related colon cancer cell proliferation is
described. The anticancer role of a newly synthesized deriva-
tive of genistein, GEN-27, was shown to have both antiprolif-
erative and anti-inflammatory properties in colon cancer cells
and monocytic cells via modulation of the NF-𝜅B pathway.
N. J. Brady et al. discuss macrophages in the con-
text of normal mammary gland development and mam-
mary tumorigenesis. The review highlights the vital role of
macrophages in mammary gland generation and homeosta-
sis, as well as their contribution to tumor formation and
progression.
B. Sainz Jr. et al. review the current literature on cancer
stem cells and macrophages. This article focuses on the
molecular crosstalk between the two cell types within the
premalignant niche and established tumors, which influences
cancer progression.
We then proceed with the introduction of neutrophils
and their function in cancer, as well as their interactions
with macrophages. Z. Granot and J. Jablonska review the
pro- and antitumor properties neutrophils exhibit, which are
regulated by cues in the tumor microenvironment. Much
like macrophages, neutrophils are not a homogeneous pop-
ulation of cells and can become either protumoral (N1) or
antitumoral (N2). Moreover, neutrophils have a major role in
generating the premetastatic niche, as indicated by the large
number of neutrophils accumulated in such sites. However,
whether neutrophils are activated as N1 or N2 is dictated
by the TME. Much remains unknown about the possible
activationmodes of neutrophils, their biologicalmarkers, and
their functions in the polarized state in the tumoral context.
M. Orozco-Morales et al. review the interplay between
molecular inflammatory mediators and the immune cells
recruited to Non-Small Cell Lung Cancer (NSCLC). They
highlight the roles played by various factors in regulating
the function of TAMs and Tumor-Associated Neutrophils
(TANs) in the context ofNSCLC. Finally, they discuss the role
of tumor cell expressed CD47 in mediating immune evasion.
The inflammatory microenvironment, as studied espe-
cially in tumors but also in inflammatory diseases such as
rheumatoid arthritis (RA), is very hypoxic, and the lack
of available oxygen influences both macrophages and neu-
trophils, as discussed by A. Egners et al.. Hypoxia induces
or activates major transcription factors, such as hypoxia
inducible factors (HIFs) 1 and 2 and NF-𝜅B, and those
in turn mediate and regulate the hypoxic stress. This is
manifested by major changes in every aspect of macrophage
and neutrophil functions, including their migration and
adhesion to endothelial cells, their ability to kill bacteria, their
metabolism and polarization, production of cytokines, and
protumorigenic activity, as reviewed in this paper.
The tumor microenvironment (TME) polarizes TAMs
and TANs to become protumoral and support tumor growth
and progression, invasiveness and metastasis, angiogenesis,
and matrix remodeling, while inhibiting the antitumoral
immune surveillance. In inflammatory microenvironments
and in TME, neutrophils can recruit macrophages, and
these, in turn, affect neutrophil functions, thereby exhibiting
different degrees of interaction between these two cell types.
KimandBae explore the biology of TAMs andTANs and their
recruitment and polarization and discuss their possible inter-
actions in the TME as well as their role in TME maintenance
and their significance in clinical settings. They concluded
that the introduction of more sophisticated tumor models
and techniques to differentiate different myeloid cell subsets
in vivo will reveal fundamental information about possible
modulation of myeloid cells, including their interaction with
platelets in each progression stage of different cancer types.
To finalize the issue, we address the role of macrophages
and neutrophils in autoimmune diseases. The involvement
of macrophages in autoimmune disease of the brain is
highlighted in a review by X. Fan et al. Although current
knowledge is quite limited, the ability of macrophages to
polarize in different activation modes and carry out different
and often opposing tasks renders them important media-
tors of the pathogenesis of diseases such as neuromyelitis
optica (NMO), myasthenia gravis (MG), and Guillain-Barre´
syndrome (GBS), and burning questions, such as whether
macrophages can be targeted or used as future therapeutic
agents, must be further explored.
Concluding this special issue is a detailed review by M.
A. Rahat and J. Shakya that draws parallels between the
cancerous and autoimmune microenvironments. From the
point of view of the immune response, cancer and autoim-
mune diseases, where the immune system is suppressed
or hyperactivated, respectively, are opposites. Nonetheless,
many elements in the microenvironments are common in
both diseases including hypoxia, angiogenesis, the presence
of autoantibodies, and cytokine concentrations. Of course,
the critical role that myeloid cells, macrophages, and neu-
trophils in particular play in these diseases and the detailed
understanding of the similarities and differences in the
two contexts may eventually lead to novel approaches to
immunotherapies.
Collectively, these papers highlight the critical impor-
tance of macrophages and neutrophils in the microenviron-
ments of both cancerous and autoimmune diseases. These
cells can sense the changing microenvironment and interpret
the signals and via complex interactions with other tissue
cells and infiltrating immune cells, including the interactions
betweenmacrophages andneutrophils themselves, they regu-
late the progression of the immune response in these diseases
[6]. These different interactions could become a focus of
research in the field in the coming years. Moreover, although
the role that macrophages play in the cancer microenvi-
ronment has been extensively studied in the last decade,
still some areas deserve more attention, for example, the
crosstalk between different microenvironmental factors such
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as hormones and hypoxia. Neutrophils bearmany similarities
to macrophages, in their secretome and their killing and
proangiogenic abilities and in the way the microenvironment
activates them in different and opposing manners. However,
this has only recently begun to be unveiled, andmore research
directed at neutrophil characterization, understanding of
their contribution, and deciphering their interactions with
different cell populations must be invested. And lastly, the
current knowledge and the findings described in this issue
point to several new insights into the mechanisms of current
and potential therapies and suggest new possible combi-
nation therapies that could benefit patients and should be
further explored.
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